• Gastrointest. Endosc. · Jul 2010

    Randomized Controlled Trial Comparative Study

    Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study.

    • Chan Gyoo Kim, Il Ju Choi, Jong Yeul Lee, Soo-Jeong Cho, Sook Ryun Park, Lee Jun Ho JH, Keun Won Ryu, Young-Woo Kim, and Young Iee Park.
    • Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
    • Gastrointest. Endosc. 2010 Jul 1; 72 (1): 25-32.

    BackgroundSelf-expandable metallic stents (SEMSs) provide effective palliation of malignant pyloric obstruction in patients with inoperable gastric cancer.ObjectiveTo compare the effectiveness and side effects of covered and uncovered SEMSs for the palliation of malignant pyloric obstruction.DesignProspective, randomized, single-center study.SettingTertiary-care cancer center hospital.PatientsThis study involved 80 patients with pyloric obstruction related to inoperable gastric cancer.InterventionCovered or uncovered SEMS placement.Main Outcome MeasurementsTechnical and clinical success rates as well as the patency rate at 8 weeks after placement.ResultsBoth groups had a technical success rate of 100% with no immediate complications. Both groups also had comparable clinical success rates (covered SEMS, 95% [38 of 40] and uncovered SEMS, 90% [36 of 40], P = .68) and 8-week patency rates (covered SEMS, 61.3% [19 of 31] and uncovered SEMS, 61.1% [22 of 36], P > .99). Stent migration within 8 weeks was more common in the covered SEMS group (25.8% [8 of 31]) than in the uncovered SEMS group (2.8% [1 of 36], P = .009), whereas re-stenosis because of tumor ingrowth was more common in the uncovered SEMS group (25.0% [9 of 36] vs 0% [0 of 31] in the covered SEMS group, P = .003). Overall patient survival and stent patency did not differ between groups (P = .27 and 0.61 by log-rank test, respectively).LimitationsThe study population was limited to gastric cancer patients, and stent designs were changed in the midst of the study period.ConclusionBoth the covered and uncovered SEMSs are effective and have comparable 8-week patency in patients with malignant pyloric obstruction, despite different patterns of late stent failure.Copyright 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…